Bristol Myers Squibb (CELG-RI) EPS (Diluted) (2009 - 2026)

Bristol Myers Squibb (CELG-RI) EPS (Diluted) (2009 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	EPS (Diluted) (Qtr)
1	Johnson & Johnson	645.88 Bn	625.12 Bn	17.26 Bn	2.27
2	AbbVie	463.46 Bn	456.89 Bn	12.70 Bn	2.04
3	Merck	367.92 Bn	360.78 Bn	12.21 Bn	-0.54
4	Novartis Ag	297.71 Bn	290.02 Bn	11.24 Bn	1.71
5	Astrazeneca	255.55 Bn	250.65 Bn	12.86 Bn	1.61
6	Amgen	234.52 Bn	220.53 Bn	7.24 Bn	4.37
7	Gilead Sciences	178.22 Bn	175.04 Bn	6.22 Bn	-8.44
8	Pfizer	158.57 Bn	146.88 Bn	10.94 Bn	-0.04
9	Gsk	105.32 Bn	101.15 Bn	8.24 Bn	0.28
10	Bristol Myers Squibb	188.27 Mn	-10.88 Bn	9.25 Bn	1.62

Download Data